Iguratimod

CAS No.

123663-49-0

MDL No.

MFCD00882374

C₁₇H₁₄N₂O₆S

374.40

InChI Key

ANMATWQYLIFGOK-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
25 mg	98%	$7	In Stock
100 mg	98%	$15	In Stock
250 mg	98%	$17	In Stock
1 g	98%	$41	In Stock
5 g	98%	$176	In Stock
10 g	98%	$329	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

25 mg

98%

In Stock

100 mg

98%

$15

In Stock

250 mg

98%

$17

In Stock

1 g

98%

$41

In Stock

5 g

98%

$176

In Stock

10 g

98%

$329

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Iguratimod is an organic molecule.

CAS No.	123663-49-0
Product Name	Iguratimod

Biological Targets

PTGS2·TRAF3IP2·MIF

Associated Conditions

graft versus host disease·autoimmune thrombocytopenic purpura·Sjogren syndrome·lupus nephritis·rheumatoid arthritis

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Iguratimod

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Iguratimod ameliorates inflammatory responses by modulating the Th17/Treg paradigm in dextran sulphate sodium-induced murine colitis.

Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.

Documentation